Main Street Financial Solutions’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.29M Buy
13,093
+3,217
+33% +$692K 0.21% 101
2026
Q1
$2.15M Sell
9,876
-533
-5% -$118K 0.16% 124
2025
Q4
$2.38M Sell
10,409
-13,644
-57% -$3.11M 0.18% 117
2025
Q3
$5.57M Buy
24,053
+1,079
+5% +$220K 0.36% 59
2025
Q2
$4.26M Buy
22,974
+3,779
+20% +$702K 0.31% 70
2025
Q1
$4.02M Sell
19,195
-156
-0.8% -$30.3K 0.35% 59
2024
Q4
$3.44M Buy
19,351
+862
+5% +$158K 0.34% 63
2024
Q3
$3.65M Sell
18,489
-108
-0.6% -$20.2K 0.34% 59
2024
Q2
$3.19M Buy
18,597
+18
+0.1% +$2.98K 0.3% 65
2024
Q1
$3.38M Buy
18,579
+146
+0.8% +$25.2K 0.36% 56
2023
Q4
$2.86M Buy
18,433
+148
+0.8% +$21.6K 0.37% 51
2023
Q3
$2.73M Buy
18,285
+720
+4% +$106K 0.39% 51
2023
Q2
$2.37M Buy
17,565
+525
+3% +$77K 0.32% 64
2023
Q1
$2.72M Buy
17,040
+25
+0.1% +$3.82K 0.4% 51
2022
Q4
$2.75M Sell
17,015
-84
-0.5% -$12.9K 0.43% 48
2022
Q3
$2.3M Buy
17,099
+2,704
+19% +$388K 0.38% 54
2022
Q2
$2.21M Buy
14,395
+847
+6% +$129K 0.28% 67
2022
Q1
$2.2M Sell
13,548
-365
-3% -$53K 0.32% 69
2021
Q4
$1.88M Sell
13,913
-3,624
-21% -$428K 0.27% 87
2021
Q3
$1.89M Buy
17,537
+1,199
+7% +$137K 0.29% 81
2021
Q2
$1.84M Buy
16,338
+780
+5% +$87.8K 0.3% 81
2021
Q1
$1.68M Buy
15,558
+5,783
+59% +$619K 0.3% 74
2020
Q4
$1.05M Buy
+9,775
New +$939K 0.21% 114

Other funds holding ABBV

Main Street Financial Solutions's ABBV Position: Q2 2026 in Review

Main Street Financial Solutions increased its AbbVie (ABBV) stake by 33% in Q2 2026, buying an estimated $692K and bringing the position to 13,093 shares worth $3.29M. The position accounts for 0.21% of the portfolio, ranked #101.

Main Street Financial Solutions first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. The position peaked at $5.57M in Q3 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Main Street Financial Solutions held 13,093 shares of AbbVie worth $3.29M as of Q2 2026.
  • Main Street Financial Solutions bought 3,217 AbbVie shares in Q2 2026, an estimated $692K.
  • AbbVie made up 0.21% of Main Street Financial Solutions's portfolio in Q2 2026, its #101 holding.
  • Main Street Financial Solutions first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • Main Street Financial Solutions's AbbVie position peaked at $5.57M in Q3 2025.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Main Street Financial Solutions's 13F filing for Q2 2026, filed 7 Aug 2026.